Literature DB >> 8771709

Secretion of a variant of human single-chain urokinase-type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of the secreted product.

M Tsujikawa1, K Okabayashi, M Morita, T Tanabe.   

Abstract

Human single-chain urokinase-type plasminogen activator without an N-glycosylation site (scu-PA-Q302) was produced in the methylotrophic yeast, Pichia pastoris using the shortened prepeptide sequence of a fungal aspartic proteinase, Mucor pusillus rennin (MPR). The level of urokinase-type plasminogen activator (u-PA) immunoreactive material in YPM medium was 0.47 mg/l; however, most of the secreted product had been processed to smaller polypeptides. The N-terminal amino acid sequence of major species was identical to that of the low molecular weight two-chain u-PA. Some approaches to minimizing the proteolysis of scu-PA-Q302 were attempted. Addition of Triton X-100, L-arginine and ammonium phosphate to the YPM medium minimized the proteolysis of scu-PA-Q302 and increased the yield of immunoreactive material to approximately 5 mg/l. Use of proteinase A- or proteinase B-deficient strains of yeast did not reduce the degradation. Co-expression of scu-PA-Q302 and urinary trypsin inhibitor resulted in partial reduction of the major species of proteolysis. Scu-PA-Q302 was purified from the culture supernatant of the improved medium by two successive chromatographies on Phenyl-Sepharose and S-Sepharose. The purified protein had a molecular weight of 47 kDa. It did not contain detectable N-linked oligosaccharides, but contained O-linked oligosaccharides attached to the light chain. N-terminal amino acid sequencing of the purified preparation showed that the shortened prepeptide sequence of MPR was correctly processed by the Pichia yeast. Scu-PA-Q302 closely resembles natural scu-PA with respect to its enzymatic activity against the chromogenic substrate S-2444 and its in vitro fibrinolytic properties.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771709     DOI: 10.1002/(SICI)1097-0061(199605)12:6%3C541::AID-YEA935%3E3.0.CO;2-A

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  7 in total

Review 1.  The yeast expression system for recombinant glycosyltransferases.

Authors:  M Malissard; S Zeng; E G Berger
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

2.  Enzyme immunoassays for specific IgG and IgE antibodies to Pichia pastoris components in normal humans.

Authors:  W Ohtani; K Kobayashi; T Ohmura
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 3.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

4.  Yeast expressed recombinant Hemagglutinin protein of novel H1N1 elicits neutralising antibodies in rabbits and mice.

Authors:  T N Athmaram; Shweta Saraswat; S R Santhosh; Anil Kumar Singh; W S Suryanarayana; Raj Priya; N Gopalan; Manmohan Parida; P V Lakshmana Rao; R Vijayaraghavan
Journal:  Virol J       Date:  2011-11-29       Impact factor: 4.099

5.  Extracellular expression of alkaline phytase in Pichia pastoris: Influence of signal peptides, promoters and growth medium.

Authors:  Mimi Yang; Sasha Teymorian; Philip Olivares; Pushpalatha P N Murthy
Journal:  Biotechnol Rep (Amst)       Date:  2015-03-26

6.  Different N-Glycosylation Sites Reduce the Activity of Recombinant DSPAα2.

Authors:  Huakang Peng; Mengqi Wang; Nan Wang; Caifeng Yang; Wenfang Guo; Gangqiang Li; Sumei Huang; Di Wei; Dehu Liu
Journal:  Curr Issues Mol Biol       Date:  2022-08-31       Impact factor: 2.976

7.  Fine-Tuned Enzymatic Hydrolysis of Organosolv Pretreated Forest Materials for the Efficient Production of Cellobiose.

Authors:  Anthi Karnaouri; Evangelos Topakas; Leonidas Matsakas; Ulrika Rova; Paul Christakopoulos
Journal:  Front Chem       Date:  2018-04-19       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.